Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ALZECURE-PHARMA-AB-61747198/news/AlzeCure-Pharma-AB-publ-prasentiert-positive-klinische-Daten-der-Phase-II-mit-ACD440-gegen-neurop-44883973/?utm_source=whatsapp&utm_medium=social&utm_campaign=share